BusinessPhoto: Business StandardCipla Q2 Net Profit Drops 35% to ₹877.5 Crore
Pharmaceutical company Cipla reported a 35% decline in consolidated net profit for Q2 ending September, at ₹877.54 crore, down from ₹1,351.17 crore the previous year. Revenue slightly decreased to ₹7,403.93 crore from ₹7,589.44 crore, while total expenses increased to ₹6,377.75 crore from ₹6,004.86 crore during the same period.
Business Standard·



